No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
JANX Janux Therapeutics
- 56.830
- +0.080+0.14%
Close Dec 20 16:00 ET
- 56.830
- 0.0000.00%
Post 16:11 ET
3.33BMarket Cap-48.57P/E (TTM)
59.720High55.630Low1.25MVolume56.370Open56.750Pre Close71.73MTurnover2.83%Turnover RatioLossP/E (Static)58.63MShares71.71052wk High5.08P/B2.51BFloat Cap7.79052wk Low--Dividend TTM44.20MShs Float71.710Historical High--Div YieldTTM7.21%Amplitude5.650Historical Low57.297Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Clear Street Launches Healthcare & Biotechnology Equity Research
Janux Therapeutics Price Target Maintained With a $200.00/Share by Cantor Fitzgerald
Janux Therapeutics Analyst Ratings
BTIG Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $100
BTIG Sticks to Its Buy Rating for Janux Therapeutics Inc (JANX)
SoundHound, Asana And Victorias Secret Are Among Top 10 Mid Cap Gainers Last Week (Dec 2-Dec 6): Are The Others In Your Portfolio?
Heat List
US
Overall
Symbol
Price
% Chg
No Data